Paras, Monica .

HRN: 00-32-59  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
METRONIDAZOLE 500MG (TAB)
06/08/2022
06/11/2022
PO
500mg
Q8
Amoebiasis
Waiting Final Action 
06/09/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/09/2022
06/15/2022
IVTT
500
Q8
Amoebiasis
Waiting Final Action 
12/01/2022
CIPROFLOXACIN 500MG (TAB)
12/01/2022
12/08/2022
PO
500mg
OD
UTI
Waiting Final Action 
01/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/27/2023
02/02/2023
IVT
500mg
Q8
Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: